DOCSLIB.ORG

Save the Date for 2022 WMRC January 20-22, 2022

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Save the Date for 2022 WMRC January 20-22, 2022 Participating Societies: Western Section American Federation for Medical Research Western Society for Pediatric Research We would like to thank the following companies for their generous support: Save the Date for 2022 WMRC January 20‐22, 2022 2021 WESTERN MEDICAL RESEARCH CONFERENCE (WMRC) PROGRAM AT-A-GLANCE January 29-30, 2021 Platform will adjust to your local time you are in. Meeting is in PST time zone TIME ACTIVITY & LOCATION FRIDAY, JANUARY 29, 2021 8:00 am – 8:10 am WELCOME 8:10 am – 9:05 am Genetics I Healthcare Research I - Therapies Neonatology – Perinatal Biology I Neuroscience I 9:05 am – 10:00 am COVID - Infectious Diseases I Healthcare Research II – Learning Morphogenesis and Malformations Neonatology General I 10:00 am – 10:10 am BREAK 10:10 am – 11:05 am Adolescent Medicine and Behavior Development I Immunology and Rheumatology Infectious Diseases I Neonatology General II 11:05 am – 12:00 pm Adolescent Medicine and Behavior Development II Endocrinology and Metabolism I Healthcare Research III – Machine Neonatology Pulmonary 12:00 pm – 1:00pm BREAK 1:00 pm – 2:20 pm AWARD SESSIONS AND PRESENTATIONS Henry Christian Award WSPR Abbott Nutrition Lowell Glasgow Student Research Award WSPR Abbott Nutrition David W. Smith Pediatric Trainee Research Award 2 WSPR Abbott Nutrition Young Investigator Research Award 2:20 pm – 3:15 pm Adolescent Medicine and Behavior Development III Hematology and Oncology Neonatology General III Surgery I 3:15 pm – 4:10 pm Genetics II Neonatology General IV Pulmonary and Critical Care Surgery II 4:10 pm – 4:20 pm BREAK 4:20 pm – 5:15 pm Gastroenterology Surgery III SATURDAY, JANUARY 30, 2021 JOINT PLENARY SESSION WAFMR and WSPR 8:00 – 8:15 am Welcome WAFMR and WSPR President 8:15 – 9:00 am WSPR Stanley Wright Lecture Healthcare Disparities Research As A Way To Improve the Healthcare System Ricardo Correa, University of Arizona College of Medicine Phoenix 9:00 am – 9:55 am Cardiovascular I Neonatology - Perinatal Biology II Neuroscience II Adolescent Medicine and Behavior Development IV 9:55 am – 10:05 am BREAK 10:05 am – 11:00 am Adolescent Medicine and Behavior Development IV (continued) Cardiovascular II Healthcare Research IV - Psychology Neonatology General V 11:00 am – 11:55 am Adolescent Medicine and Behavior Development V COVID - Infectious Diseases II Health Care Research V Neonatology General VI 11:55 am – 1:00 pm BREAK 1:00 pm – 1:55 pm Cardiovascular, Nephrology and Hypertension COVID – Health Care Research Endocrinology and Metabolism II Surgery IV 1:55 pm – 2:50 pm Health Care Research VI – Quality Improvement Infectious Diseases II Surgery V 3 2021 Western Medical Research Conference Award Winners Shinya Abe, Kobe University Graduate School of WSPR Mead Johnson Merit Award Medicine Geoanna Bautista, University of California Los Angeles AFMR Henry Christian Award Dana Button, Oregon Health & Science University WAFMR Subspecialty Award Shanlee Davis, University of Colorado WSPR Abbott Nutrition Young Investigator Research Award Tristan Dear, University of Colorado Denver School of WSPR Outstanding Resident Medicine Research Award Evgenia Dobrinskikh, University of Colorado WSPR Mead Johnson Merit Award Theodore Gross, Valley Children's Hospital WAFMR Subspecialty Award Adina Hazan, Cedars Sinai Medical Center WAFMR Subspecialty Award Sarah Kee, University of Washington WAFMR Subspecialty Award Lauren Lee, University of California Los Angeles David WSPR Abbott Nutrition Lowell Geffen School of Medicine Glasgow Student Research Award Rebecca Levy, Stanford University School of Medicine, WSPR Mead Johnson Merit Award Olivia Man, University of California Los Angeles David WAFMR Subspecialty Award Geffen School of Medicine Pranay Maniar, New Jersey Institute of Technology WAFMR Subspecialty Award Monica Penon Portmann, University of California San WSPR Mead Johnson Merit Award Francisco Hannah Peterson, Loma Linda University School of WAFMR Subspecialty Award Medicine Jonathan Repine, University of Colorado WAFMR Subspecialty Award Caitlin Ritz, University of Colorado WAFMR Subspecialty Award Amitoj Singh, University of California San Francisco WAFMR Subspecialty Award Boris Stepanyuk, University of Colorado Denver School WSPR Mead Johnson Merit Award of Medicine Katie Strobel, University of California-Los Angeles WSPR Abbott Nutrition David W, Smith Award Tania Torbati, Western University of Health Sciences WAFMR Subspecialty Award College of Osteopathic Medicine of the Pacific Alicia White, University of Colorado WSPR Mead Johnson Merit Award 4 WESTERN SECTION AMERICAN FEDERATION FOR MEDICAL RESEARCH WESTERN SOCIETY FOR PEDIATRIC RESEARCH Friday, January 29, 2021 8:00 AM – 8:10 AM 8:00 AM WELCOME ______________________________________________________________________________ CONCURRENT SESSIONS Friday, January 29, 2021 8:10 AM – 9:55 AM Jointly sponsored by WESTERN SECTION AMERICAN FEDERATION FOR MEDICAL RESEARCH WESTERN SOCIETY FOR PEDIATRIC RESEARCH Genetics I………..……………………………………………………………....Room 1 Healthcare Research I - Therapies……………………………...…………….Room 2 Neonatology - Perinatal Biology I……………………………………………..Room 3 Neuroscience I…………………………………………………………………..Room 4 _____________________________________________________________________________________________________________________ Genetics I Room 1 Anne Slavotinek, Presiding 8:10 PROSPECTIVE STUDY OF EPILEPSY IN NGLY1 DEFICIENCY. RJ Levy, CH Frater, WB Galentine and MR Ruzhnikov, Stanford, CA. Stanford University School of Medicine (Mead Johnson Merit Award Genetics) Abstract 1 8:14 CLINICAL WHOLE GENOME SEQUENCING IN YOUNG CHILDREN WITH AUTISM SPECTRUM DISORDER: A PILOT STUDY. K Wigby, T Carr, M Feddock, A Jindal, D Dimmock, S Kingsmore, J Friedman and C Hobbs, San Diego, CA. University of California, San Diego (WSPR) Abstract 2 8:18 PHENOTYPIC CHARACTERIZATION OF WAC RELATED INTELLECTUAL DISABILITY DUE TO A NOVEL SPLICING VARIANT. JA Morales, MI Valenzuela, B Isidor, I Cusco-Marti, DR Matalon and N Gomez-Ospina, Stanford, CA; Barcelona, Spain; Nantes, France. Stanford University (WSPR) Abstract 3 8:22 IDENTIFICATION OF CEP68 AS A CANDIDATE GENE FOR INSULIN CLEARANCE AND TYPE 2 DIABETES. JH Nguyen and M Peterfy, Pomona, CA. Western University of Health Sciences 5 (WSMRF) Abstract 4 8:26 URINE LUCK: A RARE CASE OF A CONGENITAL DISORDER OF GLYCOSYLATION DIAGNOSED BY URINE OLIGOSACCHARIDES. R Gates, K Cusmano-Ozog and N Gomez-Ospina, Stanford, CA. Stanford University (WSMRF) Abstract 5 8:30 SHORT BONES, RENAL STONES, AND DIAGNOSTIC MOANS: HYPERCALCEMIA IN A GIRL FOUND TO HAVE COFFIN-LOWRY SYNDROME. CG Tise, M Grover, DR Matalon and H Byers, Stanford, CA. Stanford University (WSPR) Abstract 6 8:34 NOVEL PHENOTYPE OF BONE MARROW FAILURE IN HUWE1- ASSOCIATED INTELLECTUAL DISABILITY AND SKEWING OF X- CHROMOSOME INACTIVATION IN MATERNAL BLOOD SUPPORT ROLE OF HUWE1 IN HEMATOPOESIS. C Carlston, SL Sell, JA Sullivan, S Brown, A Bentley, D Mettman, I Thiffault, P Bayrak- Toydemir and L Botto, San Francisco, CA; Hershey, PA; Durham, NC; Salt Lake City, UT; Kansas City, MO. UCSF (WAFMR) Abstract 7 8:38 A RARE CO-OCCURRENCE OF AICARDI GOUTIERES SYNDROME WITH BI-ALLELIC POLG1 VARIANTS IN A CHILD OF CONSANGUINEOUS PARENTS. AE Lee, A Feigenbaum, D Dimmock and D Malicki, San Diego, CA; La Jolla, CA. University of California San Diego Rady Children's Hospital San Diego Abstract 8 8:42 QUESTION AND ANSWERS Healthcare Research I - Therapies Room 2 Nathanael E. Phillips, Presiding 8:10 THE ACCURACY OF CLINICAL AND OBSTETRICAL POINT OF CARE ULTRASOUND (POCUS) IN ESTIMATING FETAL WEIGHT VERSUS ACTUAL BIRTH WEIGHT: A PILOT PROSPECTIVE STUDY OF RIO BRAVO FAMILY MEDICINE RESIDENCY PROGRAM. V Marquez, Bakersfield, CA. Rio Bravo Family Medicine Residency Program (WAFMR) Abstract 9 8:14 EFFECTS OF MINDFULNESS MEDITATION ON PATIENT SATISFACTION DURING URODYNAMIC STUDY. H Wagner, M Baranda, F Jellison and A Staack, Zephyrhills, FL. Loma Linda University 6 Abstract 10 8:18 THE EFFECTS OF COUGH SUPPRESSION THERAPY ON VOICE SEVERITY. D LaTour, R Hahn, B Crawley, P Krishna and T Murry, Loma Linda, CA. Loma Linda University Abstract 11 8:22 DEVELOPMENT OF A QUESTIONNAIRE ON ACCESS TO SICKLE CELL DISEASE CARE IN THE INDIGENOUS THARU POPULATION OF NEPAL. SY Starkey, K Gray, C Lanz, J Taylor, SA Lim, K Patterson and V Kapoor, Vancouver, BC, Canada. University of British Columbia (WSMRF) Abstract 12 8:26 TELEMEDICINE TRAINING TO IMPROVE HEALTHCARE ACCESS FOR SENIOR LIVING COMMUNITY RESIDENTS IN LEWISTOWN, MONTANA. W French, Seattle, WA. University of Washington School of Medicine (WSMRF) Abstract 13 8:30 KNOWLEDGE AND RISK PERCEPTION ABOUT HEPATITIS C: PRELIMINARY EVIDENCE FROM A CROSS-SECTIONAL STUDY OF ADULTS LIVING IN LOUISIANA. B Novak, K Panbechi and J Matacotta, Pomona, CA. Western University of Health Sciences College of Osteopathic Medicine of the Pacific Abstract 14 8:34 ADEQUACY OF ANESTHESIA INFORMATION RECEIVED BY PEDIATRIC PATIENTS' PARENTS AND THEIR PREFERRED METHOD OF EDUCATION. L Nguyen, La Jolla, CA. University of California San Diego Abstract 15 8:38 ADDRESSING ALCOHOL USE DISORDER IN PLAINS, MT THROUGH ONLINE MUTUAL SUPPORT GROUPS. M Napier, Spokane, WA. University of Washington School of Medicine Abstract 16 8:42 QUESTION AND ANSWERS Neonatology - Perinatal Biology I Room 3 Lisa Joss-Moore, Presiding 8:10 ANTENATAL SELENIUM DEFICIENCY DECREASES NEONATAL HEPATIC AND PLASMA GLUTATHIONE PEROXIDASE. D Balasubramaniyan, L Zheng, R de Dios, T Sizemore, E Nozik, CJ Wright and L Sherlock, Aurora, CO. University of Colorado Denver School of Medicine Abstract
Load more

Recommended publications
  • Clinical Utility Gene Card For: 3-M Syndrome – Update 2013
    European Journal of Human Genetics (2014) 22, doi:10.1038/ejhg.2013.156 & 2014 Macmillan Publishers Limited All rights reserved 1018-4813/14 www.nature.com/ejhg CLINICAL UTILITY GENE CARD UPDATE Clinical utility gene card for: 3-M syndrome – Update 2013 Muriel Holder-Espinasse*,1, Melita Irving1 and Vale´rie Cormier-Daire2 European Journal of Human Genetics (2014) 22, doi:10.1038/ejhg.2013.156; published online 31 July 2013 Update to: European Journal of Human Genetics (2011) 19, doi:10.1038/ejhg.2011.32; published online 2 March 2011 1. DISEASE CHARACTERISTICS nonsense and missense mutations c.4333C4T (p.Arg1445*) and 1.1 Name of the disease (synonyms) c.4391A4C (p.His1464Pro), respectively, render CUL7 deficient 3-M syndrome (gloomy face syndrome, dolichospondylic dysplasia). in recruiting ROC1, leading to impaired ubiquitination. OBSL1: microsatellites analysis of the locus (2q35-36.1) in con- 1.2 OMIM# of the disease sanguineous families. OBSL1: microsatellites analysis of the locus 273750. (2q35-36.1) in consanguineous families. Mutations induce non- sense mediated decay. Knockdown of OBSL1 in HEK293 cells 1.3 Name of the analysed genes or DNA/chromosome segments shows the role of this gene in the maintenance of normal levels of CUL7, OBSL1 and CCDC8.1–5 CUL7. Abnormal IGFBP2 andIGFBP5 mRNA levels in two patients with OBSL1 mutations, suggesting that OBSL1 modulates the 1.4 OMIM# of the gene(s) expression of IGFBP proteins. CCDC8: microsatellites analysis 609577 (CUL7), 610991 (OBSL1) and 614145 (CCDC8). at the locus (19q13.2-q13.32). CCDC8, 1-BP DUP, 612G and CCDC8, 1-BP.
    [Show full text]
  • Patient Advocacy Organizations, Industry Funding, and Conflicts of Interest
    Supplementary Online Content Rose SL, Highland J, Karafa MT, Joffe S. Patient advocacy organizations, industry funding, and conflicts of interest. JAMA Intern Med. Published online January 17, 2017. doi:10.1001/jamainternmed.2016.8443 eTable 1. Search Terms Used to Identify Organizations eTable 2. Inclusion and Exclusion Criteria eTable 3. Sensitivity Analysis Comparing Survey Responses of Executive and Non-Executive Respondents of Patient Advocacy Organizations (PAOs) eFigure. Survey This supplementary material has been provided by the authors to give readers additional information about their work. © 2017 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 10/01/2021 eTable 1. Search Terms Used to Identify Organizations Aagenaes Syndrome Anoxia Carcinoid Aarskog Syndrome Antiphospholipid Syndrome Carcinoma Aase-Smith Syndrome II Antley-Bixler Syndrome Cardiac Abdominal Cystic Phenotype Cardiogenic Lymphangioma Anxiety Cardiogenic Shock Abdominal Obesity Metabolic Aphasia Cardiomyopathy Syndrome Apraxia Cardiovascular Achondroplasia Arrhythmia Carotid Artery Disease Achromatopsia Arteriosclerosis Celiac Acid Lipase Disease Arthritis Central Cord Syndrome Acoustic Neuroma Asperger Syndrome Cervical Cancer Acquired Hyperostosis Aspergers Chondrodysplasia Punctata Syndrome Asthma Acrocephalosyndactylia Chordoma Astrocytoma Addison Disease Churg-Strauss Syndrome Ataxia ADHD Colon Cancer Atherosclerosis Adie's syndrome Colorectal Cancer Atrial Adrenal Hyperplasia Conduct Disorder Atrial Fibulation
    [Show full text]
  • Trim37-Deficient Mice Recapitulate Several Features of the Multi-Organ
    © 2016. Published by The Company of Biologists Ltd | Biology Open (2016) 5, 584-595 doi:10.1242/bio.016246 RESEARCH ARTICLE Trim37-deficient mice recapitulate several features of the multi- organ disorder Mulibrey nanism Kaisa M. Kettunen1,2,3,4, Riitta Karikoski5, Riikka H. Hämäläinen6, Teija T. Toivonen1, Vasily D. Antonenkov7, Natalia Kulesskaya3, Vootele Voikar3, Maarit Hölttä-Vuori8,9, Elina Ikonen8,9, Kirsi Sainio10, Anu Jalanko11, Susann Karlberg12, Niklas Karlberg12, Marita Lipsanen-Nyman12, Jorma Toppari13, Matti Jauhiainen11, J. Kalervo Hiltunen7, Hannu Jalanko14 and Anna-Elina Lehesjoki1,2,3,* ABSTRACT of the human MUL disease and thus provide a good model to study Mulibrey nanism (MUL) is a rare autosomal recessive multi-organ disease pathogenesis related to TRIM37 deficiency, including disorder characterized by severe prenatal-onset growth failure, infertility, non-alcoholic fatty liver disease, cardiomyopathy and infertility, cardiopathy, risk for tumors, fatty liver, and type 2 tumorigenesis. diabetes. MUL is caused by loss-of-function mutations in TRIM37, KEY WORDS: Mulibrey nanism, Infertility, Fatty liver, which encodes an E3 ubiquitin ligase belonging to the tripartite motif Cardiomyopathy, Tumorigenesis, Growth failure (TRIM) protein family and having both peroxisomal and nuclear localization. We describe a congenic Trim37 knock-out mouse INTRODUCTION (Trim37−/−) model for MUL. Trim37−/− mice were viable and had Mulibrey nanism (MUL) is a rare autosomal recessive multi-organ normal weight development until approximately
    [Show full text]
  • Repercussions of Inborn Errors of Immunity on Growth☆ Jornal De Pediatria, Vol
    Jornal de Pediatria ISSN: 0021-7557 ISSN: 1678-4782 Sociedade Brasileira de Pediatria Goudouris, Ekaterini Simões; Segundo, Gesmar Rodrigues Silva; Poli, Cecilia Repercussions of inborn errors of immunity on growth☆ Jornal de Pediatria, vol. 95, no. 1, Suppl., 2019, pp. S49-S58 Sociedade Brasileira de Pediatria DOI: https://doi.org/10.1016/j.jped.2018.11.006 Available in: https://www.redalyc.org/articulo.oa?id=399759353007 How to cite Complete issue Scientific Information System Redalyc More information about this article Network of Scientific Journals from Latin America and the Caribbean, Spain and Journal's webpage in redalyc.org Portugal Project academic non-profit, developed under the open access initiative J Pediatr (Rio J). 2019;95(S1):S49---S58 www.jped.com.br REVIEW ARTICLE ଝ Repercussions of inborn errors of immunity on growth a,b,∗ c,d e Ekaterini Simões Goudouris , Gesmar Rodrigues Silva Segundo , Cecilia Poli a Universidade Federal do Rio de Janeiro (UFRJ), Faculdade de Medicina, Departamento de Pediatria, Rio de Janeiro, RJ, Brazil b Universidade Federal do Rio de Janeiro (UFRJ), Instituto de Puericultura e Pediatria Martagão Gesteira (IPPMG), Curso de Especializac¸ão em Alergia e Imunologia Clínica, Rio de Janeiro, RJ, Brazil c Universidade Federal de Uberlândia (UFU), Faculdade de Medicina, Departamento de Pediatria, Uberlândia, MG, Brazil d Universidade Federal de Uberlândia (UFU), Hospital das Clínicas, Programa de Residência Médica em Alergia e Imunologia Pediátrica, Uberlândia, MG, Brazil e Universidad del Desarrollo,
    [Show full text]
  • NHSGGC Board Meeting Date of Meeting
    BOARD OFFICIAL NHS Greater Glasgow & Paper No. 20/40 Clyde Meeting: NHSGGC Board Meeting Date of Meeting: 25th August 2020 Purpose of Paper: For Noting Classification: Board Official Sponsoring Director: Medical Director and Nurse Director Clinical Governance Annual Report (including the Duty of Candour Report) 2019/2020 Recommendation The Board is asked to note the report, which has been approved for publication by the Clinical and Care Governance Committee. Purpose of Paper The Clinical Governance Annual Report provides a description of the key aspects clinical governance arrangements along with examples of improvement activities. The report contains the Duty of Candour Report, whose publication is legal requirement. The report is made publicly available via the Board’s website. Key Issues to be considered The report provides assurance of the maintenance of the clinical governance arrangements along with our Duty of Candour obligations. The report development and publication is being maintained but the process was compromised by the clinical service focus the pandemic response during the normal reporting period over April and May. 1 BOARD OFFICIAL Any Patient Safety /Patient Experience Issues Data on patient safety and experience is included in the report with assurance of learning and improvements Any Financial Implications from this Paper None specified Any Staffing Implications from this Paper None Specified Any Equality Implications from this Paper None Specified Any Health Inequalities Implications from this Paper None Specified Has a Risk Assessment been carried out for this issue? If yes, please detail the outcome. No Highlight the Corporate Plan priorities to which your paper relates Author – Head of Clinical Governance Date – August 2020 2 BOARD OFFICIAL Clinical Governance Annual Report 2019-2020 NHS GREATER GLASGOW & CLYDE Custodian: Head of Clinical Governance Issue date: July 2020 Status: Draft Version: Draft 3.0 1 BOARD OFFICIAL Section Title Page Front Page 1 Table of Contents 2 1.
    [Show full text]
  • 2021 Western Medical Research Conference
    Abstracts J Investig Med: first published as 10.1136/jim-2021-WRMC on 21 December 2020. Downloaded from Genetics I Purpose of Study Genomic sequencing has identified a growing number of genes associated with developmental brain disorders Concurrent session and revealed the overlapping genetic architecture of autism spectrum disorder (ASD) and intellectual disability (ID). Chil- 8:10 AM dren with ASD are often identified first by psychologists or neurologists and the extent of genetic testing or genetics refer- Friday, January 29, 2021 ral is variable. Applying clinical whole genome sequencing (cWGS) early in the diagnostic process has the potential for timely molecular diagnosis and to circumvent the diagnostic 1 PROSPECTIVE STUDY OF EPILEPSY IN NGLY1 odyssey. Here we report a pilot study of cWGS in a clinical DEFICIENCY cohort of young children with ASD. RJ Levy*, CH Frater, WB Galentine, MR Ruzhnikov. Stanford University School of Medicine, Methods Used Children with ASD and cognitive delays/ID Stanford, CA were referred by neurologists or psychologists at a regional healthcare organization. Medical records were used to classify 10.1136/jim-2021-WRMC.1 probands as 1) ASD/ID or 2) complex ASD (defined as 1 or more major malformations, abnormal head circumference, or Purpose of Study To refine the electroclinical phenotype of dysmorphic features). cWGS was performed using either epilepsy in NGLY1 deficiency via prospective clinical and elec- parent-child trio (n=16) or parent-child-affected sibling (multi- troencephalogram (EEG) findings in an international cohort. plex families; n=3). Variants were classified according to Methods Used We performed prospective phenotyping of 28 ACMG guidelines.
    [Show full text]
  • Constrictive Pericarditis and Primary Amenorrhea with Syndactyly in an Iranian Female: Mulibrey Nanism Syndrome
    TEHRAN HEART CENTER Case Report Constrictive Pericarditis and Primary Amenorrhea with Syndactyly in an Iranian Female: Mulibrey Nanism Syndrome Tahereh Davarpasand, MD, Maryam Sotoudeh Anvari, MD, Mohammad Naderan, MD*, Mohammad Ali Boroumand, MD, Hossein Ahmadi, MD Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran. Received 25 March 2015; Accepted 10 June 2016 Abstract Mulibrey nanism is a rare autosomal recessive syndrome caused by a mutation in the TRIM37 gene with severe growth retardation and multiple organ involvement. Early diagnosis is important because 50% of the patients develop congestive heart failure owing to constrictive pericarditis, and this condition plays a critical role in the final prognosis. A 37-year-old female patient presented with symptoms of dyspnea on exertion and shortness of breath. She had severe growth failure and craniofacial dysmorphic feature. Cardiac evaluation showed constrictive pericarditis, moderate pulmonary hypertension, and mild pericardial effusion. The patient underwent pericardiectomy, but her thick and adhesive pericardium forced the surgeon to do partial pericardiotomy. Our report underlines the importance of attention to probable Mulibrey nanism when confronting patients with primary amenorrhea, growth retardation, and dysmorphic features. Early cardiac examination is of great significance in the course of the disorder, and patients must be pericardiectomized to relieve the symptoms and increase survival. J Teh Univ Heart Ctr 2016;11(4):187-191 This paper should be cited as: Davarpasand T, Sotoudeh Anvari M, Naderan M, Boroumand MA, Ahmadi H. Constrictive Pericarditis and Primary Amenorrhea with Syndactyly in an Iranian Female: Mulibrey Nanism Syndrome. J Teh Univ Heart Ctr 2016;11(4):187-191.
    [Show full text]
  • MECHANISMS in ENDOCRINOLOGY: Novel Genetic Causes of Short Stature
    J M Wit and others Genetics of short stature 174:4 R145–R173 Review MECHANISMS IN ENDOCRINOLOGY Novel genetic causes of short stature 1 1 2 2 Jan M Wit , Wilma Oostdijk , Monique Losekoot , Hermine A van Duyvenvoorde , Correspondence Claudia A L Ruivenkamp2 and Sarina G Kant2 should be addressed to J M Wit Departments of 1Paediatrics and 2Clinical Genetics, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, Email The Netherlands [email protected] Abstract The fast technological development, particularly single nucleotide polymorphism array, array-comparative genomic hybridization, and whole exome sequencing, has led to the discovery of many novel genetic causes of growth failure. In this review we discuss a selection of these, according to a diagnostic classification centred on the epiphyseal growth plate. We successively discuss disorders in hormone signalling, paracrine factors, matrix molecules, intracellular pathways, and fundamental cellular processes, followed by chromosomal aberrations including copy number variants (CNVs) and imprinting disorders associated with short stature. Many novel causes of GH deficiency (GHD) as part of combined pituitary hormone deficiency have been uncovered. The most frequent genetic causes of isolated GHD are GH1 and GHRHR defects, but several novel causes have recently been found, such as GHSR, RNPC3, and IFT172 mutations. Besides well-defined causes of GH insensitivity (GHR, STAT5B, IGFALS, IGF1 defects), disorders of NFkB signalling, STAT3 and IGF2 have recently been discovered. Heterozygous IGF1R defects are a relatively frequent cause of prenatal and postnatal growth retardation. TRHA mutations cause a syndromic form of short stature with elevated T3/T4 ratio. Disorders of signalling of various paracrine factors (FGFs, BMPs, WNTs, PTHrP/IHH, and CNP/NPR2) or genetic defects affecting cartilage extracellular matrix usually cause disproportionate short stature.
    [Show full text]
  • Ccr Pediatric Oncology Series
    CCR PEDIATRIC ONCOLOGY SERIES CCR Pediatric Oncology Series Surveillance Recommendations for Children with Overgrowth Syndromes and Predisposition to Wilms Tumors and Hepatoblastoma Jennifer M. Kalish1, Leslie Doros2, Lee J. Helman3, Raoul C. Hennekam4, Roland P. Kuiper5, Saskia M. Maas6, Eamonn R. Maher7, Kim E. Nichols8, Sharon E. Plon9, Christopher C. Porter10, Surya Rednam9, Kris Ann P. Schultz11, Lisa J. States12, Gail E. Tomlinson13, Kristin Zelley14, and Todd E. Druley15 Abstract A number of genetic syndromes have been linked to increased cancer predisposition specialists. At this time, these recommenda- risk for Wilms tumor (WT), hepatoblastoma (HB), and other tions are not based on the differential risk between different embryonal tumors. Here, we outline these rare syndromes with at genetic or epigenetic causes for each syndrome, which some least a 1% risk to develop these tumors and recommend uniform European centers have implemented. This differentiated approach tumor screening recommendations for North America. Specifi- largely represents distinct practice environments between the cally, for syndromes with increased risk for WT, we recommend United States and Europe, and these guidelines are designed to renal ultrasounds every 3 months from birth (or the time of be a broad framework within which physicians and families can diagnosis) through the seventh birthday. For HB, we recommend work together to implement specific screening. Further study is screening with full abdominal ultrasound and alpha-fetoprotein expected to lead to modifications of these recommendations. Clin serum measurements every 3 months from birth (or the time of Cancer Res; 23(13); e115–e22. Ó2017 AACR. diagnosis) through the fourth birthday. We recommend that See all articles in the online-only CCR Pediatric Oncology when possible, these patients be evaluated and monitored by Series.
    [Show full text]
  • Review and Hypothesis: Syndromes with Severe Intrauterine Growth
    RESEARCH REVIEW Review and Hypothesis: Syndromes With Severe Intrauterine Growth Restriction and Very Short Stature—Are They Related to the Epigenetic Mechanism(s) of Fetal Survival Involved in the Developmental Origins of Adult Health and Disease? Judith G. Hall* Departments of Medical Genetics and Pediatrics, UBC and Children’s and Women’s Health Centre of British Columbia Vancouver, British Columbia, Canada Received 4 June 2009; Accepted 29 August 2009 Diagnosing the specific type of severe intrauterine growth restriction (IUGR) that also has post-birth growth restriction How to Cite this Article: is often difficult. Eight relatively common syndromes are dis- Hall JG. 2010. Review and hypothesis: cussed identifying their unique distinguishing features, over- Syndromes with severe intrauterine growth lapping features, and those features common to all eight restriction and very short stature—are they syndromes. Many of these signs take a few years to develop and related to the epigenetic mechanism(s) of fetal the lifetime natural history of the disorders has not yet been survival involved in the developmental completely clarified. The theory behind developmental origins of origins of adult health and disease? adult health and disease suggests that there are mammalian Am J Med Genet Part A 152A:512–527. epigenetic fetal survival mechanisms that downregulate fetal growth, both in order for the fetus to survive until birth and to prepare it for a restricted extra-uterine environment, and that these mechanisms have long lasting effects on the adult health of for a restricted extra-uterine environment [Gluckman and Hanson, the individual. Silver–Russell syndrome phenotype has recently 2005; Gluckman et al., 2008].
    [Show full text]
  • Nursing and the Development of Neonatal Intensive Care Units in the United States, 1955-1982
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2015 "We Were the Eyes and Ears...": Nursing and the Development of Neonatal intensive Care Units in the United States, 1955-1982. Briana Ralston University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the History Commons, and the Nursing Commons Recommended Citation Ralston, Briana, ""We Were the Eyes and Ears...": Nursing and the Development of Neonatal intensive Care Units in the United States, 1955-1982." (2015). Publicly Accessible Penn Dissertations. 1122. https://repository.upenn.edu/edissertations/1122 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/1122 For more information, please contact [email protected]. "We Were the Eyes and Ears...": Nursing and the Development of Neonatal intensive Care Units in the United States, 1955-1982. Abstract ABSTRACT "WE WERE THE EYES AND EARS...": NURSING AND THE DEVELOPMENT OF NEONATAL INTENSIVE CARE UNITS IN THE UNITED STATES, 1955-1982. Briana Ralston, MS, RN Julie Fairman, PhD, RN, FAAN In the 1960s and 1970s, neonatal intensive care units (NICUs) became the standard of care for critically ill newborns in hospitals across the United States. Though work has been done to examine how nurses participated in the development of ICU's for adult populations, scholarship related to the formation of NICUs is sparse. Using historical methodology to examine hospital archival data, oral history interviews, and scholarly literature, this work examines the roles nurses played in the development of NICUs as technological systems between 1955 and 1982 in the United States.
    [Show full text]
  • Gynecological Tumors in Mulibrey Nanism and Role for RING Finger Protein TRIM37 in the Pathogenesis of Ovarian Fibrothecomas
    Modern Pathology (2009) 22, 570–578 & 2009 USCAP, Inc All rights reserved 0893-3952/09 $32.00 www.modernpathology.org Gynecological tumors in Mulibrey nanism and role for RING finger protein TRIM37 in the pathogenesis of ovarian fibrothecomas Susann Karlberg1,2, Marita Lipsanen-Nyman2, Heini Lassus1, Jukka Kallija¨rvi3,4,5, Anna-Elina Lehesjoki3,4,5 and Ralf Butzow1,6 1Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Biomedicum Helsinki, Helsinki, Finland; 2Children’s Hospital, University of Helsinki, Helsinki, Finland; 3Folkha¨lsan Institute of Genetics, Helsinki, Finland; 4Department of Medical Genetics, University of Helsinki, Helsinki, Finland; 5Neuroscience Center, University of Helsinki, Helsinki, Finland and 6Department of Pathology, University of Helsinki, Helsinki, Finland Mulibrey nanism is an autosomal recessive growth disorder caused by mutations in the TRIM37 gene encoding a protein of unknown function. More than half of female patients with Mulibrey nanism develop benign mesenchymal tumors of ovarian sex cord–stromal origin. In this work, we characterize the gynecological tumors of female patients with Mulibrey nanism in detail. In addition to tumors of the fibrothecoma group, 18% (4/22) of the patients were observed with epithelial neoplasias, including 2 ovarian adenofibromas, 1 ovarian poorly differentiated adenocarcinoma and 1 endometrial adenocarcinoma. To investigate the possible involvement of TRIM37 alterations in the pathogenesis of sporadic fibrothecomas, we analyzed the TRIM37 cDNA for mutations and alternatively spliced transcripts and TRIM37 expression in fibrothecomas of women without Mulibrey nanism. No mutations in the open-reading frame of TRIM37 were detected. Two alternatively spliced variants were found, one lacking exon 23 and one exon 2.
    [Show full text]